Mechanism of action
HMGCoA reductase inhibitors block the synthesis of cholesterol in liver by competitively inhibiting HMGCoA reductase activity, also cause depletion of critical intracellular pools of sterols and increased transcription of LDL receptors leading to enhanced removal from plasma of LDL and LDL precursors.